Vasculitis

The Journal of Allergy and Clinical Immunology
Carol A Langford

Abstract

Vasculitis is defined by the presence of blood vessel inflammation. It can be observed in a wide variety of settings, which can be broadly grouped as secondary vasculitides, which occur in association with an underlying disease or trigger, or primary vasculitides, in which vasculitis is occurring for as-yet unknown causes. The primary systemic vasculitides comprise a range of disease entities that are uniquely identified by their clinical, histopathologic, and therapeutic characteristics. Individual diseases predominantly affect blood vessels of a particular size, which influences their clinical manifestations and has been used in their classification. The vasculitides can also differ in their severity, extending from self-limited illnesses to those that can be life-threatening in the absence of prompt initiation of treatment. Immunosuppressive agents are used to treat many vasculitic diseases. Although such approaches can be effective, the patient's long-term course can be influenced by organ damage from their initial presentation, disease relapses, and medication toxicity. Recent investigations have focused on understanding disease pathophysiology and the exploration of novel therapeutic approaches.

References

Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Apr 1, 1994·Arthritis and Rheumatism·G S HoffmanA S Fauci
Jun 1, 1994·Annals of Internal Medicine·G S KerrG S Hoffman
Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Apr 1, 1993·Ophthalmology·P D AielloG G Hunder
Apr 16, 1998·Cleveland Clinic Journal of Medicine·C A Langford
Mar 24, 1999·Arthritis and Rheumatism·L GuillevinB Jarrousse
Jan 1, 2000·Arthritis and Rheumatism·P LamprechtW L Gross
Nov 14, 2001·Dermatologic Clinics·L E Gibson
Mar 29, 2002·Arthritis and Rheumatism·Dimitrios Vassilopoulos, Leonard H Calabrese
Jul 13, 2002·Arthritis and Rheumatism·Gary S HoffmanUNKNOWN International Network for the Study of Systemic Vasculitides
Jul 26, 2002·The New England Journal of Medicine·Carlo SalvaraniGene G Hunder
Jul 4, 2003·The New England Journal of Medicine·David JayneUNKNOWN European Vasculitis Study Group
Jul 11, 2003·The New England Journal of Medicine·Cornelia M Weyand, Jörg J Goronzy
Oct 15, 2003·Arthritis and Rheumatism·Anne ProvenGene G Hunder
Apr 13, 2004·Arthritis and Rheumatism·Gideon NesherMoshe Sonnenblick
Jan 28, 2005·The New England Journal of Medicine·UNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Apr 14, 2006·Seminars in Respiratory and Critical Care Medicine·Karina A Keogh, Ulrich Specks
Aug 1, 2006·Lancet·Xavier BoschJosep Font
Sep 30, 2006·Arthritis and Rheumatism·Michael S LeeGary S Hoffman
Jan 4, 2007·Annals of Internal Medicine·Leonard H CalabreseAneesh B Singhal
Mar 1, 2007·Arthritis and Rheumatism·Kathleen Maksimowicz-McKinnonGary S Hoffman
May 2, 2007·Annals of Internal Medicine·Gary S HoffmanUNKNOWN Infliximab-GCA Study Group
Jun 22, 2007·Journal of the American Society of Nephrology : JASN·David R W JayneUNKNOWN European Vasculitis Study Group
Aug 7, 2007·Best Practice & Research. Clinical Rheumatology·Anjali NatarajaRaashid Luqmani
Oct 11, 2007·Annals of Neurology·Carlo SalvaraniGene G Hunder
Nov 3, 2007·Annals of Internal Medicine·Javier D FinkielmanUNKNOWN WGET Research Group
Dec 29, 2007·Journal of Autoimmunity·C G M Kallenberg
Jan 16, 2008·Clinical Reviews in Allergy & Immunology·Patrice Cacoub, David Saadoun
Feb 19, 2008·Current Opinion in Rheumatology·David SaadounPatrice Cacoub
Feb 21, 2008·American Journal of Clinical Dermatology·Ko-Ron Chen, J Andrew Carlson
Sep 27, 2008·Current Rheumatology Reports·Kenneth T Calamia, Phaedon G Kaklamanis
Nov 26, 2008·Best Practice & Research. Clinical Rheumatology·Sebahattin Yurdakul, Hasan Yazici
Dec 20, 2008·Current Opinion in Rheumatology·Rula A Hajj-Ali, Leonard H Calabrese

❮ Previous
Next ❯

Citations

Mar 29, 2012·Rheumatology International·Dubravka BosnićBranimir Anić
Dec 21, 2012·Internal and Emergency Medicine·Lorenzo EmmiElena Silvestri
Dec 4, 2012·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Subha V RamanWael N Jarjour
Dec 4, 2003·Environmental Health Perspectives·Karen B Mulloy
Feb 2, 2013·Indian Journal of Dermatology·Bn Nandeesh, Rajalakshmi Tirumalae
Jan 17, 2014·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Philippe BéginKari C Nadeau
Jun 21, 2014·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Mary McHenry, Wade Watson
May 7, 2013·Neurologic Clinics·Michael P CollinsJohn T Kissel
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·William T Shearer, Donald Y M Leung
Oct 17, 2013·Clinical and Experimental Immunology·G A RamirezA A Manfredi
Mar 1, 2014·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Philippe BéginKari C Nadeau
May 16, 2015·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Catherine D MiddlebrooksAlan D Castel
Dec 18, 2013·Lancet Neurology·Kelly Graham GwathmeyP James Bonham Dyck
May 1, 2010·Current Allergy and Asthma Reports·Julie Wang
Aug 22, 2012·Nature Reviews. Rheumatology·Jean-Michel VallatLaurent Magy
Sep 17, 2011·Internal Medicine·Gülfidan Aras
Oct 11, 2019·Current Opinion in Rheumatology·Patrick BolandSabina Sandigursky
Aug 30, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Jenana H MakerStephanie F James
Aug 13, 2017·Analytical and Bioanalytical Chemistry·Chung Y ChoEric A E Garber
Apr 25, 2020·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Alexandra LangloisPhilippe Bégin
May 6, 2021·Free Radical Biology & Medicine·Nan YangMing-Lin Liu
Jul 1, 2021·Curēus·Nishant AllenaBoris Medvedovsky
Oct 2, 2021·Experimental and Therapeutic Medicine·Aurelian Mihai GhitaAna Cristina Ghita

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Rachel B JonesEuropean Vasculitis Study Group
The New England Journal of Medicine
John H StoneRAVE-ITN Research Group
Arthritis Research & Therapy
Rona M SmithDavid Jayne
© 2022 Meta ULC. All rights reserved